Zions Bancorporation National Association UT Has $5.72 Million Stake in UnitedHealth Group Incorporated $UNH

Zions Bancorporation National Association UT reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,337 shares of the healthcare conglomerate’s stock after selling 2,408 shares during the period. Zions Bancorporation National Association UT’s holdings in UnitedHealth Group were worth $5,721,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Brighton Jones LLC boosted its stake in shares of UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after buying an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC boosted its position in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares during the last quarter. Gateway Wealth Partners LLC boosted its holdings in shares of UnitedHealth Group by 8.2% in the 1st quarter. Gateway Wealth Partners LLC now owns 1,253 shares of the healthcare conglomerate’s stock valued at $656,000 after buying an additional 95 shares during the last quarter. IFC Advisors LLC increased its holdings in UnitedHealth Group by 6.1% during the first quarter. IFC Advisors LLC now owns 8,454 shares of the healthcare conglomerate’s stock worth $4,428,000 after buying an additional 486 shares during the last quarter. Finally, Riversedge Advisors LLC acquired a new stake in UnitedHealth Group in the first quarter valued at $292,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Up 0.8%

Shares of UNH opened at $324.29 on Friday. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $293.75 billion, a PE ratio of 16.93, a P/E/G ratio of 2.28 and a beta of 0.47. The firm’s 50 day moving average is $345.84 and its 200-day moving average is $322.64. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. The firm had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company’s revenue was up 12.2% on a year-over-year basis. During the same quarter last year, the company earned $7.15 EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Barclays raised their target price on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. JPMorgan Chase & Co. lifted their target price on UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th. TD Cowen increased their price target on UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a research note on Thursday, October 30th. Weiss Ratings upgraded shares of UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, October 24th. Finally, UBS Group lifted their target price on shares of UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a report on Wednesday, October 29th. Eighteen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.